Novo Nordisk A/S (NVO)
48.39
-0.12 -0.25%
NYSE
Apr 18, 20:00
Delayed 2m
USD
View All Key Stats
NVO Key Stats
| Income Statement | |
| Revenue (TTM) | 17.71B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.521 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 6.139B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 84.35% |
| Profit Margin (Quarterly) | 28.58% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 115.46B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 6.628 |
| PE Ratio (TTM) | 19.20 |
| Price to Book Value | 14.54 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 614.42M |
| Return on Equity (TTM) | Upgrade |
View All NVO News
NVO News
-
WireHeadlineTime (ET)
-
Yahoo04/18 23:12
-
Yahoo04/18 09:17
-
Yahoo04/17 11:03
-
Yahoo04/17 07:48
-
Yahoo04/15 16:26
-
Yahoo04/12 07:20
-
SA Breaking News04/12 06:01
-
Yahoo04/12 04:57
-
Yahoo04/09 01:02
-
MT Newswires04/03 10:49
View All Events
NVO Events
| Date | Type | Description |
|---|---|---|
| 02/05/2020 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results in 2019 |
| 11/01/2019 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results in 2019 |
| 08/09/2019 | Earnings | Novo Nordisk A/S Second Quarter Earnings Results in 2019 |
| 08/09/2019 | Misc | Novo Nordisk A/S Second Quarter Earnings Conference Call in 2019 |
| 05/03/2019 | Earnings | Novo Nordisk A/S First Quarter Earnings Results in 2019 |
| 03/22/2019 | Dividends | Amount: 0.7887, Declared Date: Feb 05 2019, Pay Date: Apr 02 2019 |
| 03/21/2019 | Misc | Novo Nordisk A/S Annual General Meeting in 2018 |
| 02/04/2019 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results in 2018 |
| 02/04/2019 | Misc | Novo Nordisk A/S Annual Report in 2018 |
| 11/01/2018 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results in 2018 |
NVO Fundamentals
Income Statement View Statement
NVO Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
NVO One Page Reports
- One Page Report Download
NVO Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 48.39 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.novonordisk.com
- Investor Relations URL: http://www.novonordisk.com/investors.html
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Growth
- Next Earnings Release: May. 03, 2019
- Last Earnings Release: Feb. 04, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Mar. 22, 2019
- Description: Novo Nordisk A/S with almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
NVO Excel Add-In Codes
- Name: =YCI("NVO","name")
- Description: =YCI("NVO","description")
- Sector: =YCI("NVO","sector")
- Industry: =YCI("NVO","industry")
- Est. Current Fiscal Year End: =YCI("NVO","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NVO Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVO Tweets Stocktwits
Advertisement
